Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024

Charles River Laboratories slashed its outlook for 2024 due to light pharma demand, and CRL stock plummeted in early trades. The post Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024 appeared first on Investor's Business Daily.

Aug 7, 2024 - 10:25
 0  12
Charles River Labs Plummets 17% On 'Bleaker' Expectations
For 2024

Charles River Laboratories slashed its outlook for 2024 due to light pharma demand, and CRL stock plummeted in early trades.

The post Charles River Labs Plummets 17% On 'Bleaker' Expectations For 2024 appeared first on Investor's Business Daily.

iShook Opinion "iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.